Effect of maternal tocolysis on the incidence of severe periventricular/intraventricular haemorrhage in very low birthweight infants
Open Access
- 1 July 2001
- journal article
- research article
- Published by BMJ in Archives of Disease in Childhood: Fetal & Neonatal
- Vol. 85 (1) , 13F-17
- https://doi.org/10.1136/fn.85.1.f13
Abstract
AIM To examine the relation between grade III–IV periventricular/intraventricular haemorrhage (PVH/IVH) and antenatal exposure to tocolytic treatment in very low birthweight (VLBW) premature infants. STUDY DESIGN The study population consisted of 2794 infants from the Israel National VLBW Infant Database, of gestational age 24–32 weeks, who had a cranial ultrasound examination during the first 28 days of life. Infants of mothers with pregnancy induced hypertension or those exposed to more than one tocolytic drug were excluded. Of the 2794 infants, 2013 (72%) had not been exposed to tocolysis and 781 (28%) had been exposed to a single tocolytic agent. To evaluate the effect of tocolysis and confounding variables on grade III–IV PVH/IVH, the χ2test, univariate analysis, and a logistic regression model were used. RESULTS Of the 781 infants (28%) exposed to tocolysis, 341 (12.2%) were exposed to magnesium sulphate, 263 (9.4%) to ritodrine, and 177 (6.3%) to indomethacin. The overall incidence of grade III–IV PVH/IVH was 13.4%. In the multivariate logistic regression analysis, the following factors were related significantly and independently to grade III–IV PVH/IVH: no prenatal steroid treatment, low gestational age, one minute Apgar score 0–3, respiratory distress syndrome, patent ductus arteriosus, mechanical ventilation, and pneumothorax. Infants exposed to ritodrine tocolysis (but not to the other tocolytic drugs) were at significantly lower risk of grade III–IV PVH/IVH after adjustment for other variables (odds ratio = 0.3; 95% confidence interval 0.2 to 0.6). CONCLUSION This study suggests that antenatal exposure of VLBW infants to ritodrine tocolysis, in contrast with tocolysis induced by magnesium sulphate or indomethacin, was associated with a lower incidence of grade III–IV PVH/IVH.Keywords
This publication has 28 references indexed in Scilit:
- The EPICure Study: Outcomes to Discharge From Hospital for Infants Born at the Threshold of ViabilityPediatrics, 2000
- Effect of dual tocolysis on the incidence of severe intraventricular hemorrhage among extremely low-birth-weight infantsAmerican Journal of Obstetrics and Gynecology, 1996
- Maternal, Placental, and Neonatal Associations with Early Germinal Matrix/Intraventricular Hemorrhage in Infants Born Before 32 Weeks' GestationAmerican Journal of Perinatology, 1995
- PREVENTION BY MAGNESIUM OF EXOTOTOXIC NEURONAL DEATH IN THE DEVELOPING BRAIN: AN ANIMAL MODEL FOR CLINICAL INTERVENTION STUDIESDevelopmental Medicine and Child Neurology, 1995
- Antenatal steroids, delivery mode, and intraventricular hemorrhage in preterm infantsAmerican Journal of Obstetrics and Gynecology, 1995
- Low-dose indomethacin therapy and extension of intraventricular hemorrhage: A multicenter randomized trialThe Journal of Pediatrics, 1994
- Risk factors for early intraventricular hemorrhage in low birth weight infantsThe Journal of Pediatrics, 1992
- Randomized indomethacin trial for prevention of intraventricular hemorrhage in very low birth weight infantsThe Journal of Pediatrics, 1985
- Incidence and evolution of subependymal and intraventricular hemorrhage: A study of infants with birth weights less than 1,500 gmThe Journal of Pediatrics, 1978
- Intrauterine growth of live-born Caucasian infants at sea level: Standards obtained from measurements in 7 dimensions of infants born between 25 and 44 weeksPublished by Elsevier ,1969